Kensei Yahata

2.0k total citations
38 papers, 1.6k citations indexed

About

Kensei Yahata is a scholar working on Pulmonary and Respiratory Medicine, Nephrology and Molecular Biology. According to data from OpenAlex, Kensei Yahata has authored 38 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 12 papers in Nephrology and 11 papers in Molecular Biology. Recurrent topics in Kensei Yahata's work include Renal Diseases and Glomerulopathies (5 papers), Inflammatory mediators and NSAID effects (4 papers) and Renin-Angiotensin System Studies (4 papers). Kensei Yahata is often cited by papers focused on Renal Diseases and Glomerulopathies (5 papers), Inflammatory mediators and NSAID effects (4 papers) and Renin-Angiotensin System Studies (4 papers). Kensei Yahata collaborates with scholars based in Japan, United Kingdom and United States. Kensei Yahata's co-authors include Akira Sugawara, Masashi Mukoyama, Kiyoshi Mori, Kazuwa Nakao, Takayoshi Suganami, Hisashi Makino, Issei Tanaka, Akihiro Yoshimoto, Yuriko Fujinaga and Kazuhiko Takaya and has published in prestigious journals such as Current Biology, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Kensei Yahata

35 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kensei Yahata Japan 19 559 467 412 332 259 38 1.6k
M Déchaux France 27 849 1.5× 184 0.4× 242 0.6× 317 1.0× 532 2.1× 77 2.1k
Andrzej Ciechanowicz Poland 21 411 0.7× 115 0.2× 195 0.5× 127 0.4× 126 0.5× 156 1.6k
May Bloch-Faure France 22 1.1k 2.0× 117 0.3× 383 0.9× 260 0.8× 227 0.9× 29 2.1k
M. Peracchi Italy 30 293 0.5× 438 0.9× 366 0.9× 322 1.0× 69 0.3× 93 2.5k
Nicholas Moss United States 21 611 1.1× 143 0.3× 259 0.6× 86 0.3× 116 0.4× 49 2.0k
Alexander Paliege Germany 23 1.1k 1.9× 72 0.2× 319 0.8× 174 0.5× 463 1.8× 54 2.2k
Agnès Pernin Switzerland 13 818 1.5× 319 0.7× 811 2.0× 181 0.5× 32 0.1× 16 2.0k
Chantal Verdumo Switzerland 13 833 1.5× 206 0.4× 243 0.6× 115 0.3× 43 0.2× 17 1.3k
Ichiro Yokota Japan 24 716 1.3× 437 0.9× 475 1.2× 267 0.8× 31 0.1× 92 2.0k
Yan Ge China 26 805 1.4× 120 0.3× 167 0.4× 69 0.2× 499 1.9× 88 1.9k

Countries citing papers authored by Kensei Yahata

Since Specialization
Citations

This map shows the geographic impact of Kensei Yahata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kensei Yahata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kensei Yahata more than expected).

Fields of papers citing papers by Kensei Yahata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kensei Yahata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kensei Yahata. The network helps show where Kensei Yahata may publish in the future.

Co-authorship network of co-authors of Kensei Yahata

This figure shows the co-authorship network connecting the top 25 collaborators of Kensei Yahata. A scholar is included among the top collaborators of Kensei Yahata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kensei Yahata. Kensei Yahata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yahata, Kensei, Koichi Seta, Keita Mori, et al.. (2024). Prospective randomized trial of antibiotic prophylaxis for percutaneous renal biopsy. Clinical and Experimental Nephrology. 29(3). 269–275.
3.
Nishioka, Keisuke, Akira Sugawara, Yuka Sugawara, et al.. (2023). A case of malignant hypertension as a presentation of atypical hemolytic uremic syndrome. PubMed. 11(1). 72–78.
4.
Yahata, Kensei, Akihiro Yoshimoto, Koichi Seta, et al.. (2022). Antibiotic prophylaxis for percutaneous renal biopsy: study protocol for a prospective randomized trial. Trials. 23(1). 646–646. 1 indexed citations
5.
Ueda, Naoko, et al.. (2021). Nivolumab-associated glomerular endothelial injury in a patient with gastric cancer. CEN Case Reports. 10(4). 576–581.
7.
Imasawa, Toshiyuki, Hiroo Ikehira, Hiroyuki Fujikawa, et al.. (2012). Predicting the outcome of chronic kidney disease by the estimated nephron number: The rationale and design of PRONEP, a prospective, multicenter, observational cohort study. BMC Nephrology. 13(1). 11–11. 10 indexed citations
8.
Nanba, Kazutaka, et al.. (2011). A rare case of malignant-phase hypertension with pulmonary alveolar hemorrhage. Clinical and Experimental Nephrology. 15(2). 303–307. 7 indexed citations
9.
Makino, Hisashi, Masashi Mukoyama, Kiyoshi Mori, et al.. (2006). Transgenic overexpression of brain natriuretic peptide prevents the progression of diabetic nephropathy in mice. Diabetologia. 49(10). 2514–2524. 37 indexed citations
10.
Yahata, Kensei, Kiyoshi Mori, Masashi Mukoyama, et al.. (2003). Regulation of stanniocalcin 1 and 2 expression in the kidney by klotho gene. Biochemical and Biophysical Research Communications. 310(1). 128–134. 27 indexed citations
11.
Makino, Hisashi, Issei Tanaka, Masashi Mukoyama, et al.. (2002). Prevention of Diabetic Nephropathy in Rats by Prostaglandin E Receptor EP1-Selective Antagonist. Journal of the American Society of Nephrology. 13(7). 1757–1765. 96 indexed citations
12.
Yoshimoto, Akihiro, Kiyoshi Mori, Akira Sugawara, et al.. (2002). Plasma Ghrelin and Desacyl Ghrelin Concentrations in Renal Failure. Journal of the American Society of Nephrology. 13(11). 2748–2752. 223 indexed citations
13.
Yokoi, Hideki, Akira Sugawara, Masashi Mukoyama, et al.. (2001). Role of connective tissue growth factor in profibrotic action of transforming growth factor-β: A potential target for preventing renal fibrosis. American Journal of Kidney Diseases. 38(4). S134–S138. 132 indexed citations
14.
Suganami, Takayoshi, Masashi Mukoyama, Akira Sugawara, et al.. (2001). Overexpression of Brain Natriuretic Peptide in Mice Ameliorates Immune-Mediated Renal Injury. Journal of the American Society of Nephrology. 12(12). 2652–2663. 67 indexed citations
15.
Nagae, Tetsuya, Masashi Mukoyama, Akira Sugawara, et al.. (2000). Rat Receptor-Activity-Modifying Proteins (RAMPs) for Adrenomedullin/CGRP Receptor: Cloning and Upregulation in Obstructive Nephropathy. Biochemical and Biophysical Research Communications. 270(1). 89–93. 98 indexed citations
16.
Mori, Kiyoshi, Kensei Yahata, Masashi Mukoyama, et al.. (2000). Disruption of klotho Gene Causes an Abnormal Energy Homeostasis in Mice. Biochemical and Biophysical Research Communications. 278(3). 665–670. 53 indexed citations
17.
Kasahara, Masato, Masashi Mukoyama, Akira Sugawara, et al.. (2000). Ameliorated Glomerular Injury in Mice Overexpressing Brain Natriuretic Peptide with Renal Ablation. Journal of the American Society of Nephrology. 11(9). 1691–1701. 56 indexed citations
18.
Yahata, Kensei, Kiyoshi Mori, Hiroshi Arai, et al.. (2000). Molecular cloning and expression of a novel klotho-related protein. Journal of Molecular Medicine. 78(7). 389–394. 47 indexed citations
19.
Tsujioka, Masatsune, et al.. (1999). A unique talin homologue with a villin headpiece-like domain is required for multicellular morphogenesis in Dictyostelium. Current Biology. 9(7). 389–394. 49 indexed citations
20.
Yahata, Kensei, Issei Tanaka, Masato Kotani, et al.. (1999). Identification of a novel R642C mutation in NA/CL cotransporter with Gitelman's syndrome. American Journal of Kidney Diseases. 34(5). 845–853. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026